相关实验视频
Updated: Jan 15, 2026
08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
肺结核诊断分子检测的经济评估:一个系统的审查
Natthakan Chitpim1, Panida Yoopetch2, Jiraphun Jittikoon3
1Social, Economic and Administrative Pharmacy (SEAP) Graduate Program, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
ClinicoEconomics and outcomes research : CEOR
|October 7, 2025
概括
像Xpert MTB/RIF和TB-LAMP这样的快速分子测试对于在高负担地区诊断肺结核 (TB) 是具有成本效益的. 政策制定者应该专注于降低成本和实施系统,以最大限度地提高经济效益.
科学领域:
- 全球卫生经济学 全球卫生经济学
- 传染病诊断 传染病诊断 传染病诊断
- 公共卫生政策 公共卫生政策
背景情况:
- 肺结核 (TB) 诊断依赖于各种方法,快速分子分析提供速度,但比传统的涂抹显微镜更高的成本.
- 高负担设置需要具有成本效益的诊断策略,以有效地管理成年肺结核病的假设.
研究的目的:
- 提供WHO认可的分子诊断试验的最新经济综合,用于在高负担环境中对成年肺结核的假定诊断.
- 为了比较Xpert MTB/RIF和TB-LAMP与传统诊断策略的成本效益.
主要方法:
- 为了获得全面的经济评估,在Medline,Embase和Scopus进行了系统的文献搜索,直到2025年3月.
- 研究将分子测试 (Xpert MTB/RIF,TB-LAMP) 与涂抹显微镜,培养或被动病例发现进行了比较.
- 数据被提取,成本调整为2025美元,并使用CHEERS 2022评估报告质量. 由于异质性,结果以叙事形式进行了综合,ICERs被上下文化.
主要成果:
- 包括来自高结核病负担的低收入和中等收入国家的8项研究,评估了Xpert MTB/RIF和TB-LAMP.
- 大多数研究报告每DALYs避免或QALYs获得的成本,高CHEERS报告质量 (中位数23/28).
- 分子测试的增量成本效益比率 (ICER) 与国家特定的门相比,始终节省成本或具有高度成本效益. 敏感性分析显示,成本效益的可能性很高.
结论:
- 目前的证据强烈支持Xpert MTB/RIF和TB-LAMP用于诊断成人肺结核的成本效益和成本节约潜力.
- 建议决策者优先降低分子测试盒子成本.
- 建议实施患者一级的效益捕获模型,以最大限度地发挥这些先进诊断工具的经济优势.
相关概念视频
01:26Pulmonary Tuberculosis IV
474
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
474
01:28Pulmonary Tuberculosis V
534
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
534
01:31Pulmonary Tuberculosis III
931
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
931
01:29Pulmonary Tuberculosis I
827
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
827
01:28Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K